Breast tumor characteristics as predictors of mammographic detection: Comparison of interval- and screen-detected cancers

被引:218
作者
Porter, PL
El-Bastawissi, AY
Mandelson, MT
Lin, MG
Khalid, N
Watney, EA
Cousens, L
White, D
Taplin, S
White, E
机构
[1] Fred Hutchinson Canc Res Ctr, Program Canc Biol, Div Human Biol, Seattle, WA 98109 USA
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[4] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[5] Grp Hlth Cooperat Puget Sound, Dept Radiol, Seattle, WA 98101 USA
[6] Univ Washington, Dept Family Med, Seattle, WA 98195 USA
关键词
D O I
10.1093/jnci/91.23.2020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although mammographic screening is useful for detecting early breast cancer, some tumors are detected in the interval between screening examinations. This study attempted to characterize fully the tumors detected in the two different manners. Methods: Our study utilized a case-control design and involved a cohort of women undergoing mammographic screening within the defined population of a health maintenance organization (the Group Health Cooperative of Puget Sound). Women were classified as having "interval" or "interval-detected'' cancers (n = 150) if their diagnosis was made within 24 months after a negative-screening mammogram or one that indicated a benign condition. Cancers were classified as "screen detected" (n = 279) if the diagnosis occurred after a positive assessment by screening mammography. Tumors from women in each group were evaluated for clinical presentation, histology, proliferative characteristics, and expression of hormone receptors, p53 tumor suppressor protein, and c-erbB-2 protein. Results: Interval-detected cancers occurred more in younger women and were of larger tumor size than screen-detected cancers. In unconditional logistic regression models adjusted for age and tumor size, tumors with lobular (odds ratio [OR] = 1.9; 95% confidence interval [CI] = 0.9-4.2) or mucinous (OR = 5.5; 95% CI=1.5-19.4) histology, high proliferation (by either mitotic count [OR = 2.9; 95% CI = 1.5-5.7] or Ki-67 antigen expression [OR = 2.3; 95% CI = 1.3-4.1]), high histologic grade (OR = 2.1; 95% CI = 1.2-4.0), high nuclear grade (OR = 2.0; 95% Cf = 1.0-3.7), or negative estrogen receptor status (OR 1.8; 95% CI = 1.0-3.1) were more likely to surface in the interval between screening examinations. Tumors with tubular histology (OR = 0.2; 95% CI = 0.0-0.8) or with a high percentage of in situ components (50%) (OR = 0.5; 95% CI = 0.2-1.2) were associated with an increased likelihood of screen detection. Conclusions: Our data from a large group of women in a defined population indicate that screening mammography may miss tumors of lobular or mucinous histology and some rapidly proliferating, high-grade tumors.
引用
收藏
页码:2020 / 2028
页数:9
相关论文
共 50 条
[31]   Mammography screening interval and the frequency of interval cancers in a population-based screening [J].
Klemi, PJ ;
Toikkanen, S ;
Rasanen, O ;
Parvinen, I ;
Joensuu, H .
BRITISH JOURNAL OF CANCER, 1997, 75 (05) :762-766
[32]   Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography [J].
Laya, MB ;
Larson, EB ;
Taplin, SH ;
White, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (10) :643-649
[33]   CASE-CONTROL STUDY OF FACTORS ASSOCIATED WITH FAILURE TO DETECT BREAST-CANCER BY MAMMOGRAPHY [J].
MA, L ;
FISHELL, E ;
WRIGHT, B ;
HANNA, W ;
ALLAN, S ;
BOYD, NF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (10) :781-785
[34]   BREAST-CANCER MISSED BY MAMMOGRAPHY [J].
MARTIN, JE ;
MOSKOWITZ, M ;
MILBRATH, JR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1979, 132 (05) :737-739
[36]   INTERVAL CANCERS AND SENSITIVITY IN THE SCREENING CENTERS OF THE UK TRIAL OF EARLY DETECTION OF BREAST-CANCER [J].
MOSS, SM ;
COLEMAN, DA ;
ELLMAN, R ;
CHAMBERLAIN, J ;
FORREST, APM ;
KIRKPATRICK, AE ;
THOMAS, BA ;
PRICE, JL .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (02) :255-258
[37]   INTERLEUKIN-2-MEDIATED ELIMINATION OF THE P27(KIP1) CYCLIN-DEPENDENT KINASE INHIBITOR PREVENTED BY RAPAMYCIN [J].
NOURSE, J ;
FIRPO, E ;
FLANAGAN, WM ;
COATS, S ;
POLYAK, K ;
LEE, MH ;
MASSAGUE, J ;
CRABTREE, GR ;
ROBERTS, JM .
NATURE, 1994, 372 (6506) :570-573
[38]  
OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612
[39]   CYCLIN-DEPENDENT REGULATION OF G(1) IN MAMMALIAN FIBROBLASTS [J].
OHTSUBO, M ;
ROBERTS, JM .
SCIENCE, 1993, 259 (5103) :1908-1912
[40]  
PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO